Labelling and in vivo biodistribution of Ga-68-labelled tris(hydroxypyridinone)-conjugated anti-PSMA single-chain antibody fragment in a mouse model of human prostate cancer

Nawaz S.; Kampmeier F.; Mullen G.; Ballinger J. R.; Blower P. J.

首页> 外文期刊>The Journal of Nuclear Medicine >Labelling and in vivo biodistribution of Ga-68-labelled tris(hydroxypyridinone)-conjugated anti-PSMA single-chain antibody fragment in a mouse model of human prostate cancer

【24h】

Labelling and in vivo biodistribution of Ga-68-labelled tris(hydroxypyridinone)-conjugated anti-PSMA single-chain antibody fragment in a mouse model of human prostate cancer

机译：Ga-68标记的三（羟基吡啶酮）偶联的抗PSMA单链抗体片段的标记和体内生物分布在人类前列腺癌的小鼠模型中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Nuclear Medicine》 |2015年第2期|共1页
作者
Nawaz S.; Kampmeier F.; Mullen G.; Ballinger J. R.; Blower P. J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Labelling and in vivo biodistribution of Ga-68-labelled tris(hydroxypyridinone)-conjugated anti-PSMA single-chain antibody fragment in a mouse model of human prostate cancer [J] . Nawaz S., Kampmeier F., Mullen G., The Journal of Nuclear Medicine . 2015,第Suppla2期

机译：Ga-68标记的三（羟基吡啶酮）偶联的抗PSMA单链抗体片段的标记和体内生物分布在人类前列腺癌的小鼠模型中
2. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. [J] . He J, Wang Y, Feng The Journal of Nuclear Medicine . 2010,第3期

机译：使用快速内在化的新型人单链抗体片段在体内靶向前列腺癌细胞。
3. Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment [J] . Jiang He, Yong Wang, Jinjin Feng, The Journal of Nuclear Medicine . 2010,第3期

机译：使用快速内在化的新型人类单链抗体片段体内靶向前列腺癌细胞
4. ~(177)Lu-DOTA-J591 MONOCLONAL ANTIBODY: CHEMISTRY, TOXICITY, DOSIMETRY AND CLINICAL EFFICACY: RIT OF PROSTATE CANCER USING ~(177)LU-J591 ANTI-PSMA ANTIBODY [C] . S.J. GOLDSMITH, S. VALLABHAJOSULA, M.I. MILOWSKY, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：〜（177）Lu-DOTA-J591单克隆抗体：化学，毒性，剂量和临床疗效：使用〜（177）LU-J591抗-PSMA抗体的前列腺癌
5. Analysis of biodistribution and therapeutic efficacy of a novel labeled antibodies based technique in the treatment of cancer with mice model [D] . John, Benjamin Bello 2006

机译：一种基于标记抗体的新型技术在小鼠模型中的生物治疗分布和疗效分析
6. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging [O] . Barbara Frigerio, Gerben Franssen, Elena Luison, 2017

机译：123I标记的抗PSMA抗体片段ScFvD2B在前列腺癌成像中的全面临床前验证
7. Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer : Aspects of labeling chemistry and biodistribution [O] . Tolmachev, Vladimir, Malmberg, Jennie, Estrada, Sergio, 2014

机译：I-124标记版本的抗PSMA单克隆抗体capromab用于前列腺癌免疫PET分期的开发：标记化学和生物分布的各个方面

Labelling and in vivo biodistribution of Ga-68-labelled tris(hydroxypyridinone)-conjugated anti-PSMA single-chain antibody fragment in a mouse model of human prostate cancer

著录项

相似文献

相关主题

期刊订阅